Skip to main content

Advertisement

Log in

Growth hormone effect on body composition in Turner syndrome

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

This study analyzes the body composition of young adult women with Turner syndrome (TS) either treated or not treated with recombinant human growth hormone (rhGH) and compares them with a group of healthy women. Fifty-two non-treated TS patients (23.0 ± 5.8 years), 30 treated with rhGH (21.5 ± 1.5 years), and 133 healthy young adult women (22.9 ± 3.2 years) were evaluated regarding height (H) and weight, body mass index (BMI), brachial perimeter and tricipital cutaneous fold (fat and lean areas at the arm), sitting height (SRH = sitting height/H × 100), leg length (leg/H), waist and hip circumferences (waist/hip), and bioimpedance (percentages of water, lean mass, and fat mass). Age at start of rhGH therapy varied from 7.8 to 15.1 years (10.0 ± 1.3 years), duration of treatment from 2.8 to 8.2 years (3.7 ± 1.5 years), and the mean dose was 0.42 mg/kg/w (from 0.32 to 0.50 mg/kg/w). Body composition (except height) did not differ between TS groups, but there were differences when compared to the control group: weight and sitting height were lower in TS patients; and BMI, SHR, and leg/H were higher. There was an association between all groups with regards to BMI, waist, SHR, and leg/H, but not in percentage of fat mass. SHR was positively correlated with BMI, waist, hip, and percentage of fat mass. This sample of TS patients (with and without rhGH therapy) did not differ in BMI or body composition. However, there were differences between patients with TS patients and normal healthy women. Regardless of rhGH therapy, TS patients should be monitored, particularly for sitting height, SHR, leg length, leg/H, and waist/hip.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M.B. Ranke, P. Saenger, Turner’s syndrome. Lancet 358, 309–314 (2001)

    Article  PubMed  CAS  Google Scholar 

  2. M.B. Ranke, Growth in Turner’s syndrome. Acta Paediatr. 83, 343–344 (1994)

    Article  PubMed  CAS  Google Scholar 

  3. M.L. Davenport, N. Punyasavatsut, D. Gunther, L. Savendahl, P.W. Stewart, Turner syndrome: a pattern of early growth failure. Acta Paediatr. Suppl. 88, 118–121 (1999)

    Article  PubMed  CAS  Google Scholar 

  4. S.H. De Lemos-Marini, A.M. Morcillo, M.T. Baptista, G. Guerra-Jr, A.T. Maciel-Guerra, Spontaneous final height in Tuner′s syndrome in Brazil. J. Pediatr. Endocrionol. Metab. 20, 1207–1214 (2009)

    Article  Google Scholar 

  5. C.A. Bondy, Turner Syndrome Study Group, Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J. Clin. Endocrinol. Metab. 92, 10–25 (2007)

    Article  PubMed  CAS  Google Scholar 

  6. V.K. Bakalov, M.M. Cooley, M.J. Quon, M.L. Luo, J.A. Yanovski, L.M. Nelson, Impaired insulin secretion in the Turner metabolic syndrome. J. Clin. Endocrinol. Metab. 89, 3516–3520 (2004)

    Article  PubMed  CAS  Google Scholar 

  7. T. Morgan, Turner syndrome: diagnosis and management. Am. Fam. Physician 76, 405–410 (2007)

    PubMed  Google Scholar 

  8. C. Lichiardopol, M. Mota, D. Braicu, C. Militaru, F. Mixich, Diabetes mellitus and Turner syndrome. Rom. J. Intern. Med. 45, 299–304 (2007)

    PubMed  Google Scholar 

  9. C.H. Gravholt, B.E. Hjerrild, L. Mosekilde, T.K. Hansen, L.M. Rasmussen, J. Frystyk, Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol. 155, 583–592 (2006)

    Article  PubMed  CAS  Google Scholar 

  10. J. Lo, Does growth hormone therapy benefit body composition and glucose homeostasis in girls with Turner syndrome? Nat. Clin. Pract. Endocrinol. Metab. 4, 596–597 (2008)

    Article  PubMed  CAS  Google Scholar 

  11. M. Elsheikh, G.S. Conway, The impact of obesity on cardiovascular risk factors in Turner’s syndrome. Clin. Endocrinol. 49, 447–450 (1998)

    Article  CAS  Google Scholar 

  12. P.R. Blackett, A.C. Rundle, J. Frane, S.L. Blethen, Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy. Int. J. Obes. Relat. Metab. Disord. 24, 232–235 (2000)

    Article  PubMed  CAS  Google Scholar 

  13. N. Wooten, V.K. Bakalov, S. Hill, C.A. Bondy, Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J. Clin. Endocrinol. Metab. 93, 2109–2114 (2008)

    Article  PubMed  CAS  Google Scholar 

  14. M. Ari, V.K. Bakalov, S. Hill, C.A. Bondy, The effects of growth hormone treatment on bone mineral density and body composition in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 91, 4302–4359 (2006)

    Article  PubMed  CAS  Google Scholar 

  15. J.A. Delgado, C.M. Trahms, V.P. Sybert, Measurement of body fat in Turner syndrome. Clin. Genet. 29, 291–297 (1986)

    Article  PubMed  CAS  Google Scholar 

  16. T. Isojima, S. Yokoya, J. Ito, R. Horikawa, T. Tanaka, Inconsistent determination of overweight by two anthropometric indices in girls with Turner syndrome. Acta Paediatr. 98, 513–518 (2009)

    Article  PubMed  Google Scholar 

  17. A.R. Frisancho, New norms of upper limb fat and muscle areas for assessment of nutritional status. Am. J. Clin. Nutr. 34, 2540–2545 (1981)

    PubMed  CAS  Google Scholar 

  18. R.F. Kuschner, Bioelectrical impedance analysis: a review of principles and applications. J. Am. Coll. Nutr. 11, 199–209 (1992)

    Google Scholar 

  19. E.C. Corrigan, L.M. Nelson, V.K. Bakalov, J.A. Yanovski, V.H. Vanderhoof, L.B. Yanoff, C.A. Bondy, Effects of ovarian failure and X-chromosome deletion on body composition and insulin sensitivity in young women. Menopause 13, 911–916 (2006)

    Article  PubMed  Google Scholar 

  20. F. Darendeliler, Z. Aycan, E. Cetinkaya, S. Vidilisan, F. Bas, A. Bideci, F. Demirel, Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome. Horm. Res. 68, 1–7 (2007)

    Article  PubMed  CAS  Google Scholar 

  21. C.H. Gravholt, R.W. Naeraa, Reference values for body proportions and body composition in adult women with Ulrich-Turner syndrome. Am. J. Med. Genet. 72, 403–408 (1997)

    Article  PubMed  CAS  Google Scholar 

  22. A.D. Baldin, T. Fabbri, A.A. Siviero-Miachon, A.M. Spinola-Castro, S.H.V. Lemos-Marini, M.T.M. Baptista, L.F.R. D’Souza-Li, A.T. Maciel-Guerra, G. Guerra-Junior, Effects of growth hormone on body proportions in Turner syndrome compared with non-treated patients and normal women. J. Endocrinol. Invest. 33, 691–695 (2010)

    PubMed  CAS  Google Scholar 

  23. A.M. Ottesen, L. Aksglaede, J. Garn, N. Tartaglia, F. Tassane, C.H. Gravholt, A. Bojesen, K. Sorensen, J. Niels, E. Rajpert-de-Meyts, T. Gerdes, A.-M. Lind, S. Kjaergaard, A. Juul, Increased number of sex chromosomes affects height in nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am. J. Med. Genet. A 152A, 1206–1212 (2010)

    Article  PubMed  Google Scholar 

  24. G. Binder, Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm. Res. Paediatr. 75, 81–89 (2011)

    Article  PubMed  CAS  Google Scholar 

  25. E.N.N. Bannink, R.L.F. van der Palsen, P.G.H. Mulden, Long-term follow-up of GH-treated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm. Res. 71, 336–342 (2009)

    Article  PubMed  CAS  Google Scholar 

  26. L.A. Menke, T.C.I. Sas, G.R.I. Zandwjjken, M.A.I. de Ridder, T. Stjinen, S.M.P.F. de Munick Keizer-Schrama, B.J. Otten, J.M. Wit, The effect of oxandrolone on body proportions and body composition in growth hormone treated girls with Turner syndrome. Clin. Endocrinol. 73, 212–219 (2010)

    CAS  Google Scholar 

  27. L. Hagenäs, T. Hertel, Skeletal dysplasia, growth hormone treatment, body proportion: comparison with other syndromic and non-syndromic short children. Horm. Res. 60(suppl 3), 65–70 (2003)

    PubMed  Google Scholar 

  28. B. Bogin, M.I. Varela-Silva, Leg length, body proportion, and health: a review with note on beauty. Int. J. Environ. Res. Public Health 7, 1047–1075 (2010)

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the National Council for Scientific and Technological Development (CNPq) for providing research fellowship (to GG-Jr) and the Coordination for Higher Level Graduates Improvement (CAPES) for providing doctoral scholarship (to ADB).

Conflicts of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gil Guerra-Junior.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baldin, A.D., Fabbri, T., Siviero-Miachon, A.A. et al. Growth hormone effect on body composition in Turner syndrome. Endocrine 40, 486–491 (2011). https://doi.org/10.1007/s12020-011-9504-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-011-9504-z

Keywords

Navigation